U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 146

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
ChrMT:5782-13922
GRCh38:
ChrMT:5782-13922
Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemiaLikely pathogenic
(Nov 4, 2014)
criteria provided, single submitter
2.
GRCh37:
ChrMT:5794-14876
GRCh38:
ChrMT:5794-14876
Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemiaLikely pathogenic
(Nov 4, 2014)
criteria provided, single submitter
3.
GRCh37:
ChrMT:6003-11220
GRCh38:
ChrMT:6003-11220
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
4.
GRCh37:
ChrMT:6468-15586
GRCh38:
ChrMT:6468-15586
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
5.
GRCh37:
ChrMT:7126-13988
GRCh38:
ChrMT:7126-13988
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
6.
GRCh37:
ChrMT:7730-11255
GRCh38:
ChrMT:7730-11255
MT-CO3, MT-ND3, MT-ATP6, MT-ATP8, MT-CO2, MT-ND4, MT-ND4L, MT-TG, MT-TK, MT-TRMitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
7.
GRCh37:
ChrMT:8290-13040
GRCh38:
ChrMT:8290-13040
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
8.
GRCh37:
ChrMT:8350-13450
GRCh38:
ChrMT:8350-13450
Pearson syndromePathogenic
(Jun 12, 2019)
no assertion criteria provided
9.
GRCh37:
ChrMT:8470-13446
GRCh38:
ChrMT:8470-13446
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
10.
GRCh37:
ChrMT:8480-13440
GRCh38:
ChrMT:8480-13440
Pearson syndromePathogenic
(Jun 12, 2019)
no assertion criteria provided
11.
GRCh37:
ChrMT:8585-12965
GRCh38:
ChrMT:8585-12965
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
12.
GRCh37:
ChrMT:8815-13722
GRCh38:
ChrMT:8815-13722
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
13.
GRCh37:
ChrMT:8839-14895
GRCh38:
ChrMT:8839-14895
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
14.
GRCh37:
ChrMT:10105-15066
GRCh38:
ChrMT:10105-15066
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
15.
GRCh37:
ChrMT:10775
GRCh38:
ChrMT:10775
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
16.
GRCh37:
ChrMT:10776
GRCh38:
ChrMT:10776
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
17.
GRCh37:
ChrMT:10785
GRCh38:
ChrMT:10785
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
18.
GRCh37:
ChrMT:10791
GRCh38:
ChrMT:10791
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
19.
GRCh37:
ChrMT:10798
GRCh38:
ChrMT:10798
MT-ND4not providedLikely benign
(Mar 8, 2017)
criteria provided, single submitter
20.
GRCh37:
ChrMT:10845
GRCh38:
ChrMT:10845
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
21.
GRCh37:
ChrMT:10857
GRCh38:
ChrMT:10857
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
22.
GRCh37:
ChrMT:10863
GRCh38:
ChrMT:10863
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
23.
GRCh37:
ChrMT:10887
GRCh38:
ChrMT:10887
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
24.
GRCh37:
ChrMT:10895
GRCh38:
ChrMT:10895
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
25.
GRCh37:
ChrMT:10899
GRCh38:
ChrMT:10899
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
26.
GRCh37:
ChrMT:10907
GRCh38:
ChrMT:10907
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
27.
GRCh37:
ChrMT:10911
GRCh38:
ChrMT:10911
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
28.
GRCh37:
ChrMT:10913
GRCh38:
ChrMT:10913
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
29.
GRCh37:
ChrMT:10914
GRCh38:
ChrMT:10914
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
30.
GRCh37:
ChrMT:10915
GRCh38:
ChrMT:10915
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
31.
GRCh37:
ChrMT:10920
GRCh38:
ChrMT:10920
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
32.
GRCh37:
ChrMT:10922
GRCh38:
ChrMT:10922
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
33.
GRCh37:
ChrMT:10931
GRCh38:
ChrMT:10931
MT-ND4not provided, Leigh syndromeConflicting interpretations of pathogenicity
(Oct 17, 2019)
criteria provided, conflicting interpretations
34.
GRCh37:
ChrMT:10932
GRCh38:
ChrMT:10932
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
35.
GRCh37:
ChrMT:10947-15537
GRCh38:
ChrMT:10947-15537
MT-TL2, MT-TS2, MT-CYB, MT-ND4, MT-ND5, MT-ND6, MT-TE, MT-THPearson syndromePathogeniccriteria provided, single submitter
36.
GRCh37:
ChrMT:11004
GRCh38:
ChrMT:11004
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
37.
GRCh37:
ChrMT:11013
GRCh38:
ChrMT:11013
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
38.
GRCh37:
ChrMT:11016
GRCh38:
ChrMT:11016
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
39.
GRCh37:
ChrMT:11016
GRCh38:
ChrMT:11016
MT-ND4not providedUncertain significance
(Jun 26, 2017)
criteria provided, single submitter
40.
GRCh37:
ChrMT:11025
GRCh38:
ChrMT:11025
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
41.
GRCh37:
ChrMT:11032
GRCh38:
ChrMT:11032
MT-ND4EpendymomaUncertain significance
(Dec 29, 2017)
no assertion criteria provided
42.
GRCh37:
ChrMT:11039
GRCh38:
ChrMT:11039
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
43.
GRCh37:
ChrMT:11043
GRCh38:
ChrMT:11043
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
44.
GRCh37:
ChrMT:11061
GRCh38:
ChrMT:11061
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
45.
GRCh37:
ChrMT:11069
GRCh38:
ChrMT:11069
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
46.
GRCh37:
ChrMT:11084
GRCh38:
ChrMT:11084
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
47.
GRCh37:
ChrMT:11087
GRCh38:
ChrMT:11087
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
48.
GRCh37:
ChrMT:11090
GRCh38:
ChrMT:11090
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
49.
GRCh37:
ChrMT:11111
GRCh38:
ChrMT:11111
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
50.
GRCh37:
ChrMT:11120
GRCh38:
ChrMT:11120
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
51.
GRCh37:
ChrMT:11129
GRCh38:
ChrMT:11129
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
52.
GRCh37:
ChrMT:11139
GRCh38:
ChrMT:11139
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
53.
GRCh37:
ChrMT:11144
GRCh38:
ChrMT:11144
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
54.
GRCh37:
ChrMT:11150
GRCh38:
ChrMT:11150
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
55.
GRCh37:
ChrMT:11151
GRCh38:
ChrMT:11151
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
56.
GRCh37:
ChrMT:11157
GRCh38:
ChrMT:11157
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
57.
GRCh37:
ChrMT:11167
GRCh38:
ChrMT:11167
MT-ND4not providedLikely benign
(Sep 25, 2015)
criteria provided, single submitter
58.
GRCh37:
ChrMT:11172
GRCh38:
ChrMT:11172
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
59.
GRCh37:
ChrMT:11177
GRCh38:
ChrMT:11177
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
60.
GRCh37:
ChrMT:11204
GRCh38:
ChrMT:11204
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
61.
GRCh37:
ChrMT:11223
GRCh38:
ChrMT:11223
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
62.
GRCh37:
ChrMT:11232
GRCh38:
ChrMT:11232
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
63.
GRCh37:
ChrMT:11246
GRCh38:
ChrMT:11246
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
64.
GRCh37:
ChrMT:11252
GRCh38:
ChrMT:11252
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
65.
GRCh37:
ChrMT:11253
GRCh38:
ChrMT:11253
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
66.
GRCh37:
ChrMT:11255
GRCh38:
ChrMT:11255
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
67.
GRCh37:
ChrMT:11263-15374
GRCh38:
ChrMT:11263-15374
MT-ND6, MT-TE, MT-TH, MT-CYB, MT-ND4, MT-ND5, MT-TL2, MT-TS2Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
68.
GRCh37:
ChrMT:11268
GRCh38:
ChrMT:11268
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
69.
GRCh37:
ChrMT:11289
GRCh38:
ChrMT:11289
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
70.
GRCh37:
ChrMT:11301
GRCh38:
ChrMT:11301
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
71.
GRCh37:
ChrMT:11318
GRCh38:
ChrMT:11318
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
72.
GRCh37:
ChrMT:11337
GRCh38:
ChrMT:11337
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
73.
GRCh37:
ChrMT:11360
GRCh38:
ChrMT:11360
MT-ND4Leber optic atrophy, Leigh syndrome, Seizure
Uncertain significance
(Oct 17, 2019)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
ChrMT:11361
GRCh38:
ChrMT:11361
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
75.
GRCh37:
ChrMT:11363
GRCh38:
ChrMT:11363
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
76.
GRCh37:
ChrMT:11393
GRCh38:
ChrMT:11393
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
77.
GRCh37:
ChrMT:11428
GRCh38:
ChrMT:11428
MT-ND4not providedLikely benign
(Sep 14, 2016)
criteria provided, single submitter
78.
GRCh37:
ChrMT:11443
GRCh38:
ChrMT:11443
MT-ND4Visual impairment, Optic atrophy, Optic neuritis,
Central scotoma, Optic neuropathy
Uncertain significance
(Jan 1, 2017)
criteria provided, single submitter
79.
GRCh37:
ChrMT:11447
GRCh38:
ChrMT:11447
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
80.
GRCh37:
ChrMT:11453
GRCh38:
ChrMT:11453
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
81.
GRCh37:
ChrMT:11467
GRCh38:
ChrMT:11467
MT-ND4not specified, Mitochondrial diseaseConflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
ChrMT:11498
GRCh38:
ChrMT:11498
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
83.
GRCh37:
ChrMT:11560
GRCh38:
ChrMT:11560
MT-ND4not providedLikely benign
(Oct 9, 2015)
criteria provided, single submitter
84.
GRCh37:
ChrMT:11577
GRCh38:
ChrMT:11577
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
85.
GRCh37:
ChrMT:11582
GRCh38:
ChrMT:11582
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
86.
GRCh37:
ChrMT:11583
GRCh38:
ChrMT:11583
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
87.
GRCh37:
ChrMT:11590
GRCh38:
ChrMT:11590
MT-ND4not providedUncertain significance
(Jan 2, 2017)
criteria provided, single submitter
88.
GRCh37:
ChrMT:11615
GRCh38:
ChrMT:11615
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
89.
GRCh37:
ChrMT:11620-11621
GRCh38:
ChrMT:11620-11621
MT-ND4Leigh syndromeLikely pathogenic
(Oct 17, 2019)
criteria provided, single submitter
90.
GRCh37:
ChrMT:11634
GRCh38:
ChrMT:11634
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
91.
GRCh37:
ChrMT:11654
GRCh38:
ChrMT:11654
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
92.
GRCh37:
ChrMT:11696
GRCh38:
ChrMT:11696
MT-ND4Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
93.
GRCh37:
ChrMT:11708
GRCh38:
ChrMT:11708
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
94.
GRCh37:
ChrMT:11711
GRCh38:
ChrMT:11711
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
95.
GRCh37:
ChrMT:11733
GRCh38:
ChrMT:11733
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
96.
GRCh37:
ChrMT:11777
GRCh38:
ChrMT:11777
MT-ND4Mitochondrial diseaseLikely pathogenic
(Jun 30, 2022)
reviewed by expert panel
FDA Recognized Database
97.
GRCh37:
ChrMT:11778
GRCh38:
ChrMT:11778
MT-ND4Mitochondrial diseasePathogenic
(Jun 30, 2022)
reviewed by expert panel
FDA Recognized Database
98.
GRCh37:
ChrMT:11781
GRCh38:
ChrMT:11781
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
99.
GRCh37:
ChrMT:11792
GRCh38:
ChrMT:11792
MT-ND4Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
100.
GRCh37:
ChrMT:11807
GRCh38:
ChrMT:11807
MT-ND4Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination